As of Feb 20, 2025, Johnson & Johnson Intrinsic Value is $196.6. This suggests it may be undervalued by 23.1% compared to its current price of around $159.6.

What is Johnson & Johnson DCF (discounted cash flow) valuation?

As of Feb 20, 2025, Johnson & Johnson's Discounted Cash Flow (DCF) valuation estimates its share price at $226.8. This suggests it may be overvalued by 42.1% to its current price of around $159.6, using a discount rate of 7.1% and terminal growth rate of 3.0%.

Is Johnson & Johnson overvalued or undervalued?

Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $196.6, compared to a market price of around $159.6. This suggests a potential undervaluation of 23.1%.